Keyphrases
Phenylephrine
100%
Contractile Properties
100%
Hypertrophy
100%
Metabolic Therapy
100%
Glucose Uptake
57%
Structural Change
42%
Functional Change
42%
Hypertrophic Markers
28%
Protein Synthesis
28%
Metabolism
14%
Phosphorylation
14%
Protein Production
14%
Pharmacological Intervention
14%
Causal Role
14%
In Vitro Model
14%
Cardiac Dysfunction
14%
Cardiac Hypertrophy
14%
Cardiomyocytes
14%
Cardiac Energy Metabolism
14%
Glucose Utilization
14%
Glucose Transporter 4 (GLUT4)
14%
Contractile Function
14%
Metabolic Changes
14%
Substrate Metabolism
14%
Cellular Glucose Uptake
14%
Rat Cardiomyocytes
14%
Marker Expression
14%
Pathological Changes
14%
Signaling Kinases
14%
Adrenergic Stimulation
14%
Uptake Function
14%
Dipyridamole
14%
Promising Strategies
14%
Kinase Protein
14%
INIS
interventions
100%
in vitro
100%
hypertrophy
100%
glucose
85%
uptake
71%
metabolism
42%
proteins
42%
synthesis
42%
rats
14%
stimulation
14%
energy
14%
phosphorylation
14%
failures
14%
kinases
14%
substrates
14%
adrenergics
14%
pathological changes
14%
dipyridamole
14%
Medicine and Dentistry
In Vitro
100%
Phenylephrine
100%
Glucose Uptake
71%
Protein Synthesis
42%
Cardiac Muscle Cell
28%
Adrenergic Stimulation
14%
Ventricular Hypertrophy
14%
Energy Metabolism
14%
Glucose Transporter 4
14%
Glucose Utilization
14%
Dipyridamole
14%
Kinase Signaling
14%
Contractile Function
14%
Protein Kinase B Inhibitor
14%
Biochemistry, Genetics and Molecular Biology
Phenylephrine
100%
Glucose Transport
71%
Protein Biosynthesis
42%
Metabolic Pathway
28%
Cardiac Muscle Cell
28%
Adrenergic Stimulation
14%
Energy Metabolism
14%
GLUT4
14%
Glucose Utilization
14%
Pharmacology, Toxicology and Pharmaceutical Science
Phenylephrine
100%
Protein Kinases
14%
Glucose Transporter 4
14%
Protein Kinase B Inhibitor
14%
Heart Ventricle Hypertrophy
14%
Dipyridamole
14%